Research Article

Parts, Period, and Extraction Solvents as Parameters Influencing Harungana madagascariensis Lam. ex Poir. (Hypericaceae) Antibacterial Activity

Table 1

Sensitivity and resistance profile of the bacterial strains used for the experiment.

Bacteria characteristics

Escherichia coli
ATCC 10536 reference strain
ATCC 8739 reference strain
E.C 99 clinical isolate: IPMS, AXI, NORS, CFMS, CROS, CIPS, ANI, CHLS
E.C 136 clinical isolate: IPMS, AXR, NORS, CFMS, CROS, CIPS, ANS, CHLS
E.C 137 clinical isolate: IPMS, AXS, NORS, CFMS, CROS, CIPS, ANI, CHLS
E.C 2 clinical isolate: TZPS, CTXS, CAZS, ES, IPMS, FURS, AMPR, TICR, GNR, TOBR, ANR, NALR, SIPR, OFLR
E.C 4 clinical isolate: CTXS, CAZS, ES, IPMS, GNS, TOBS, FURS, AMPR, TICR, TZPR, NAR, CIPR, OFXR
E.C 5 clinical isolate: TEPS, CTXS, CAZS, ES, IPMS, ANS, GNS, TOBS, CIPS
Citrobacter freundii
CIT B 80 clinical isolate: STXR, DOR, GNR, AMCR, TER, CIPR, CHLR, AKS, CTS, AXR, CROR, CAZR, IPMS, NORR, ANS
CIT B 81 clinical isolate: STXS, DOI, GNS, AMCR, TER, CIPS, CHLS, AKS, CTS, AXR, CROR, CAZS, IPMS, NORS, ANS
Serratia marcescens
SERB 115 clinical isolate: STXR, DOR, GNS, AMCS, TER, CIPS, CHLS, AKS, CTS, AXR, CROS, CAZS, IPMS, NORS, ANS
Yersinia enterocolitica
YERB 121 clinical isolate: STXS, DOR, GNS, AMCS, TER, CIPS, CHLS, ANS, CTR, AXR, CROI, CAZI, IPMS, NORS, ANS
YERBI clinical isolate: STXS, DOR, GNS, AMCR, TER, CIPS, CHLR, AKS, CTR, AXR, CROI, CAZI, IPMS, NORI, ANS
Enterobacter aerogenes
ENT 51 clinical isolate: STXR, DOR, GNS, AMCI, TER, CIPS, CHLS, AKS, CTR, AXR, CROS, CAZI, IPMS, NORS, ANI
ENT 119 clinical isolate: IPMS, AXI, NORS, CFMS, CROS, CIPS, ANI, CHLS
ENT 167 clinical isolate: STXR, DOR, GNS, AMCR, TER, CIPI, CHLS, AKS, CTR, AXR, CROI, CAZI, IPMS, NORR, ANR
Klebsiella pneumoniae
KL 111 clinical isolate: IPMS, AXI, NORS, CFMS, CROI, CIPS, ANI, CHLS
KLPB101 clinical isolate: STXS, DOS, GNS, AMCI, TES, CIPS, CHLS, AKS, CTS, AXI, CROI, CAZS, IPMS, NORS, ANS
Salmonella enterica serovar typhi
ATCC 6539 reference strain
SAL 9 clinical isolate: IPMS, AXR, NORS, CFMS, CROR, CIPS, ANI, CHLI
Sal clinical isolate: AMI, IPMS, AXS, NORS, ANI, CFMS, CROR, CIPS, ANI, CHLS
Salmonella paratyphi B clinical isolate: AMR, TER, SXTR, ANR, CIPS, CHLS
Salmonella typhimurium clinical isolate: AMR, TER, SXTR, NAR, CIPS, CHLS
Pseudomonas aeruginosa
ATCC 27853 reference strain
Providencia stuartii
PS NEA 16 clinical isolate MDR: protein synthesis inhibitor OmpF of OmpC
Bacteria Gram-positive
Staphylococcus aureus
STAPH 1 clinical isolate: IPMS, DOS, AMCS, ES, VAS
MRSA 9 resistant clinical isolate: OFXR, FLXR, KR, ER, CHLR, IMP/CSR
MRSA 11 resistant clinical isolate: OFXR, KR, ER, CIPR, IM/CSR
MRSA 12 resistant clinical isolate: OFXR, FLXR, KR, ER, IM/CSR
MRSA 3 resistant clinical isolate: OFXR, KR, ER, TER
3 clinical isolate: IPMS, AMCS, AMS, DOS, VAS, ES
ST 120 clinical isolate: IPMS, AXS, AMS, DOS, VAS, ES
SA 3 clinical isolate: CCR, QUIS/DALS, LINS, VAR, TER, TIGS, NITS, RIFR, TRIR/SULR
Streptococcus sp.
STR 7 clinical isolate: CCS, QUIS, LINs, VAS, TER, TIGS, NITS, STXR

AK: amikacin; AM: ampicillin; CHL: chloramphenicol; CFM: cefixime; CIP: ciprofloxacin; CRO: ceftriaxone; DO: doxycycline; E: erythromycin; FLX: flomoxef; IM/CS: imipenem/sodium cilastatin; K: kanamycin; NA: nalidixic acid; NOR: norfloxacin; OFX: ofloxacin; TE: tetracycline; STX: cotrimoxazole; AMC: amoxicillin + clavulanic acid; AX: amoxicillin; AZM: azithromycin; CAZ: ceftazidim; CC: clindamycin; CN: cefalexin; CT: ceftolozane + tazobactam; IPM: imipenem; L: lincomycin; NOR: norfloxacin; TE: tetracycline; QUI: quinupristin; LIN: linezolid; TIG: tigecycline; NIT: nitrofurantoin; RIF: rifampicin; VA: vancomycin; GN: gentamicin; TOB: tobramycin; TIC: ticarcillin; TZP: piperacillin/tazobactam; CTX: cefotaxime; R: resistant; S: sensitive; I: intermediate.